Physician profile

Jeffrey G Carr

Interventional Cardiology · Tyler, TX

NPI 1649260373

$1,886,392.90

in general payments reported to CMS, 2019-2025

56 companies · $16K in 2025

The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$85,540.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$10,450.00
Acquisitions$8,289.32
Food and Beverage$6,647.36
Travel and Lodging$1,611.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Bard Peripheral Vascular, INC. $1,620,834.33 2019-2025 Venclose Maven Catheter, Rotarexs 6 F X 135 Cm, Venovo
Medtronic Vascular, INC. $80,026.18 2019-2020
Philips North America LLC $61,737.03 2019-2024 (9520) Igt Devices Undivided
Medtronic, INC. $41,234.01 2021-2025 In.Pact Admiral, Hawkone, Turbohawk
Venclose INC. $38,098.99 2019-2020
Abbott Laboratories $21,625.94 2020-2024 Esprit
Cordis US Corp. $5,579.07 2023-2025 Mynx Control Venous, Brite Tip, Selution Slr Pta
W. L. Gore & Associates, INC. $4,427.66 2019
Boston Scientific Corporation $3,785.42 2019-2025 Ekosonic, Varithena Administration Pack
Intact Vascular, INC. $2,094.23 2019
Cardiovascular Systems INC. $772.25 2019-2023 Diamondback Coronary
Janssen Pharmaceuticals, INC $723.20 2019-2024 Xarelto
Avinger INC. $611.75 2019-2023 Pantheris
Shockwave Medical, INC $450.83 2024-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Angiodynamics, INC. $446.96 2022-2024 Auryon Laser System 100-120 Vac
Show all 53 companies
CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $399.47 2019-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $321.95 2019-2024 Lifevest
Merck Sharp & Dohme LLC $321.49 2021-2024 Verquvo
Biotronik INC. $269.66 2020-2022
Inspiremd LTD $257.14 2024-2025 Cguard Prime Carotid Stent System, Cguard
Heartflow, INC. $202.52 2021-2024 Ffrct
E.R. Squibb & Sons, L.L.C. $181.32 2019-2024 Camzyos, Eliquis
Amgen INC. $170.29 2019-2022
Abiomed $146.84 2022-2025
Vasorum USA INC. $138.28 2023 Celt Acd
Penumbra, INC. $136.24 2022
Ablative Solutions, INC. $133.51 2022
Gilead Sciences, INC. $110.77 2019
Endologix LLC $99.40 2024 Torus Stent Graft System, Endocross Device
Reflow Medical INC $97.06 2024
Cardiva Medical, INC. $91.62 2022-2023 Cardiva Vascade Mvp Vvcs 6-12f
Novo Nordisk INC $91.23 2022-2023 Ozempic, Rybelsus
Astellas Pharma US INC $81.90 2019-2021
Sanofi-Aventis U.S. LLC $76.77 2019-2024
Alnylam Pharmaceuticals INC. $75.90 2021-2022
Boehringer Ingelheim Pharmaceuticals, INC. $70.10 2020-2023 Jardiance
Atricure, INC. $68.75 2022
Cvrx, INC. $55.26 2022
Astrazeneca Pharmaceuticals LP $53.94 2019-2024 Farxiga
Irhythm Technologies, INC. $30.90 2022-2024 Zio Xt Patch, Zio Monitor
Veryan Medical Incorporated $29.55 2021
Siemens Medical Solutions USA, INC. $27.70 2023-2024 Artis Icono Biplane, Artis Icono Floor
Lundbeck LLC $27.26 2019-2021
Acist Medical Systems, INC. $24.26 2019
Esperion Therapeutics, INC. $23.19 2020
Cardinal Health 200 LLC $22.89 2021
Becton, Dickinson and Company $21.00 2023
Kiniksa Pharmaceuticals International, Plc $15.75 2024 Arcalyst
Asahi Intecc USA, INC. $15.37 2022
Lexicon Pharmaceuticals, INC. $14.59 2023 Inpefa
Cmp Pharma, INC. $14.27 2022
Amarin Pharma, INC. $13.69 2021
Pfizer INC. $13.22 2023

3 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$800,002.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey G Carr

$1,886,392.90

in general payments reported 2019-2025

Years
2019-2025
Top company
Bard Peripheral Vascular, INC.
Context
The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/165563/jeffrey-g-carr

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.